News

London-based platform launches PCOS treatment programme

By Published On: May 15, 2023
London-based platform launches PCOS treatment programme

The UK-based women’s health platform The Female Curve has launched a new treatment programme to support women with PCOS.

The PCOS treatment programme is a minimum of 12 weeks and aims to help women take control of their health through lifestyle interventions and one-to-one coaching.

PCOS is a hormonal disorder that affects about one in every ten women in the UK, causing a range of symptoms including irregular periods, acne, weight gain, hair loss and/or growth, and infertility.

Traditionally, women presenting with PCOS are prescribed birth control as a means of “curing” their symptoms.

However, studies have shown that lifestyle changes, defined as structured dietary, exercise or behavioural interventions, could improve reproductive, anthropometric and metabolic features and quality of life in women with PCOS.

“We know that PCOS can be a challenging condition to manage, both physically and emotionally,” explains founder Evgenia Koroleva.

“Through our programme, our team of experts is dedicated to helping women with PCOS achieve optimal health and well-being.

“Everything we do is driven by the demands of our community, the real women whose health and fitness needs aren’t being met by the one-size-fits-all set of recommendations created from centuries of male bias.

“We are changing that, and this programme is testament to that.”

The Female Curve’s initiative focuses on implementing a number of lifestyle changes to address key drivers of PCOS symptoms, such as hyperandrogenism and insulin resistance, and restore hormone balance.

It includes a resistance training plan, guidance on improving sleep hygiene, meal plans, advice on macronutrient tracking, as well as supplement and menstrual tracking.

The company is set to launch additional programmes on its platform, including a PMS management plan, an egg-freezing preparation programme and a coming-off-the-pill programme.

FDA approves new menopause drug to treat hot flashes
Esco Medical selects Fairtility’s CHLOE EQ as AI decision support tool for MIRI Time-Lapse Incubators